A study published in PLOS PATHOGENS describes the prevalence and functions of mutations in neuraminidase enzyme of avian H5N1 influenza viruses that are preferentially selected in human H5N1 influenza ...

The impact of influenza infection is felt globally each year when the disease develops in approximately 20 percent of the world's population. In the United States, influenza infections occur in ...

Scientists say they have found an antibody that protects mice against a wide range of potentially lethal influenza viruses, which may lead to the design of a universal vaccine that could either treat ...

Please provide your email address to receive an email when new articles are posted on . As 2017 closes out, national influenza activity is increasing. All 10 US regions characterized by the CDC have ...

Researchers from Leiden University, University of York, University of Barcelona/IQTCUB/ICREA and The Francis Crick Institute report a new class of experimental compounds that powerfully block ...

The debate on antivirals' effectiveness and safety has led to some uncertainty within the public health community regarding their potential benefits as a treatment option or as prophylaxis for ...

Compounds that target brain cancer have been recently developed by researchers. The team synthesized a first-of-its-kind inhibitor that prevents the activity of an enzyme called neuraminidase.

INFLUENZA A viruses of human and avian origin have a common (type-specific), ribonucleoprotein antigen which is located in the virus particle. Haemagglutination-inhibition (HI) tests and strain ...

We know how the flu is spread. We know the importance of getting a flu shot. But what we may not know is the difference between the strains, and how they are named. While a bit "inside biology" for ...

An international research group, led by Jamey Marth, Ph.D., a professor at Sanford Burnham Prebys, has shown that the Neuraminidase 3 (Neu3) enzyme is responsible for the onset and progression of ...